Plasmin/Plasminogen and Kallikrein/Kinin Systems
Activated by coagulation factor XIIa, plasma kallikrein (KLKB1) cleaves high molecular weight kininogen (HK) to release bradykinin, the potent vasodilator peptide. The resulting HKa is a multi-function protein consisting of a heavy chain with three cystatin-like domains and a light chain with two domains, one of which is also known as kininostatin. KLKB1 can also activate factor XII and plasminogen/PLG, and the latter can also be activated by u- or t-Plasminogen Activator (PA). Plasmin degrades fibrin, initiating fibrinolysis. PAs and plasmin are inhibited by serpin E1 and F2, respectively. Interaction of uPA and uPAR leads to a variety of consequences.
- Angiostatin
- Annexin A2
- Bradykinin RB1/BDKRB1
- Bradykinin RB2/BDKRB2
- Kallikrein 1
- Kallikrein 3/PSA
- Kallikrein 4/Prostase/EMSP1
- Kallikrein 5
- Kallikrein 6/Neurosin
- Kallikrein 7
- Kallikrein 10
- Kallikrein 13
- Kallikrein 14
- Plasma Kallikrein/KLKB1
- Kininogen
- Kininogen/Kininostatin
- Kininostatin
- PGK1
- Plasminogen
- S100A10
- Serpin A4/Kallistatin
- Serpin B2
- Serpin E1/PAI-1
- Serpin F2/alpha 2-Antiplasmin
- t-Plasminogen Activator/tPA
- u-Plasminogen Activator (uPA)/Urokinase
- uPAR